Table II.
Item | n | miR-146a expression | P-value | miR-146b expression | P-value |
---|---|---|---|---|---|
Age (years) | 0.0692 | 0.0782 | |||
≤50 | 37 | 5.98±1.33 | 3.53±1.08 | ||
<50 | 36 | 6.16±1.28 | 3.85±1.12 | ||
GA125 (U/ml) | 0.0619 | 0.0873 | |||
≤35 | 43 | 5.87±1.08 | 5.63±1.62 | ||
>35 | 30 | 6.16±1.22 | 5.57±1.29 | ||
FIGO staging | 0.0538 | 0.0686 | |||
Stage I–II | 28 | 6.29±1.39 | 6.08±1.19 | ||
Stage III–IV | 45 | 6.89±1.87 | 5.95±2.01 | ||
Lymphatic metastasis | 0.0078 | 0.0097 | |||
Yes | 36 | 6.76±2.01 | 6.73±1.78 | ||
No | 37 | 3.58±1.96 | 2.17±1.05 | ||
Recurrence | 0.0086 | 0.0176 | |||
Yes | 17 | 5.97±1.86 | 5.32±1.25 | ||
No | 56 | 2.38±1.29 | 3.17±1.03 |